查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1457036

医用气体和设备市场 - 2024年至2029年预测

Medical Gas and Equipment Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 110 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

医用气体及设备市场预计复合年增长率为9.21%，市场规模从2022年的628.29亿美元增加到2029年的1163.74亿美元。

医用气体及设备被认为是医疗设备的一类，包括氮气、氧气、氦气等。医用气体设备市场可分为纯气体、空气、氧化亚氮、以及包括二氧化碳在内的一种或多种成分的混合气体三大类。医疗设备包括人工呼吸器、氧气浓缩机、气体输送系统、麻醉仪器、呼吸治疗仪、高压舱、医用气瓶等。这些设备在各个医疗领域都很重要，并受到 FDA 等监管机构的品质和安全监管。

癌症、糖尿病、气喘和心血管疾病等慢性疾病的增加是加速医用气体设备市场成长的主要驱动因素。此外，早产率的快速上升和呼吸道疾病盛行率的增加，特别是随着吸烟者数量的增加和污染水平的上升，正在推动市场领域的发展。

此外，各种公共机构的参与支持采用这种医用气体设备进一步推动了领域规模的发展。此外，FDA 于 2019 年发布了有关 CGMP 法规更新的公告，包括供应隔间和封闭件的氧气输送必需品的新设计，以及易于区分的新颜色和标籤。这进一步降低了风险的气体污染。

市场驱动因素：

  • 医院需求的增加预计将推动市场成长

医用气体和设备在医院行业中发挥着重要作用，随着世界各地医院数量的增加，医院行业的需求大幅增长。这里有各种各样的医疗设备，包括低温产品、流量计、调节器，甚至医用空气压缩机，为需要重症加护的患者提供高效的治疗。因此，这些设备已成为整个医院（从加护病房(ICU) 到手术室 (OT)）的中流砥柱。

随着医疗保健产业对医用气体和设备的需求增加，多个政府基金对医疗保健产业的投资也在增加，推动市场成长。以印度为例，自从政府允许医疗保健产业的外国直接投资（FDI）以来，印度的医疗保健产业一直在快速扩张。根据世界卫生组织(WHO)的数据，自2000年以来，越南人均GDP每成长1%，越南的公共卫生支出就会增加1.7%。

  • 慢性病盛行率上升将加速市场成长

由于慢性呼吸系统疾病、心血管疾病、居家医疗需求、人口老化、重症加护和紧急护理、预防性医疗措施、技术进步以及对呼吸健康的日益关注，医用气体和设备市场将持续增长，预计将出现增长。慢性呼吸道疾病（如慢性阻塞性肺病和气喘）需要医用气体（如氧气）进行治疗，而心血管疾病（包括心臟衰竭）可能需要氧气来治疗呼吸困难的患者。人们对家庭医疗保健的日益偏好正在推动对可携式和家用医用气体设备的需求，包括氧气疗法和其他呼吸支援设备。医用气体输送系统和设备的技术进步有助于改善患者照护和慢性病管理。关注呼吸系统健康的公共卫生宣传活动和倡议也有助于提高对慢性呼吸系统疾病的认识，从而实现早期诊断和治疗。

预计北美将占据大部分市场占有率

在预测期内，北美市场可能会出现急剧成长。北美医用气体设备市场在市场占有率和收益方面占据主导地位，预计在预测期内将保持其主导地位。北美地区主要企业的存在以及完善的医疗保健（包括製药地区）是导致北美在医用气体设备市场占据主导地位的一些驱动因素。北美先进的医疗基础设施、严格的监管标准、高昂的医疗成本、技术进步以及日益增长的居家医疗需求，造就了其在医用气体和设备行业的主导市场地位。

此外，由于存在多个医疗机构，据说美国的销售额很高。此外，美国目前家庭治疗的使用率不断增加，导致医用气体设备市场的标准甚至分析水准不断提高，包括各种输送程序。

目录

第一章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章医用气体和设备市场：按类型

  • 介绍
  • 医用气体
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
    • 氧
    • 二氧化碳
    • 氮
    • 氧化亚氮
    • 医用空气
    • 氦
  • 医用气体设备
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章医用气体及设备市场：依应用分类

  • 介绍
  • 治疗条件
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 呼吸治疗
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 心血管治疗
    • 市场机会趋势
    • 成长前景
    • 地域盈利
  • 其他的
    • 市场机会趋势
    • 成长前景
    • 地域盈利

第七章医用气体和设备市场：依最终使用者分类

  • 介绍
  • 医院
    • 市场机会趋势
    • 成长前景
    • 地域盈利
  • 家庭保健
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 製药公司
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域盈利

第八章医用气体及设备市场：按地区

  • 介绍
  • 北美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 有竞争力的仪表板

第十章 公司简介

  • The Linde Group
  • Praxair Technology, Inc.
  • Delta P Srl
  • Rotarex
  • SOL SPA
  • Messer Group
  • Medicop
  • Amico Group of Companies
  • Precision UK Ltd（a subsidiary of Indutrade）
  • MEC Medical Ltd.
  • Air Liquide
  • Air Products and Chemicals, Inc.
  • TAIYO NIPPON SANSO CORPORATION
  • GCE Group
  • Atlas Copco AB
简介目录
Product Code: KSI061612247

The medical gas and equipment market is expected to grow at a CAGR of 9.21%, reaching a market size of US$116.374 billion in 2029 from US$62.829 billion in 2022.

Medical gases and equipment are regarded as a category of medical equipment that includes nitrogen, oxygen, and helium among others. The medical gas equipment market can be classified into three categories such as that of pure gas, and mixtures of one or more components including air, nitrous oxide, and carbon dioxide which are regarded to be essential in multiple healthcare and medical applications. Medical equipment includes ventilators, oxygen concentrators, gas delivery systems, anaesthesia machines, respiratory therapy devices, hyperbaric chambers, and medical gas cylinders. These devices are crucial in various medical disciplines and are regulated by regulatory bodies like the FDA for quality and safety.

The rise in a few chronic disorders such as cancer, diabetes, asthma, and cardiovascular disorders will act as a major driver accelerating the medical gas-equipment market's growth rate. Moreover, the upsurge relating to the incidences of preterm births, and the growing prevalence of respiratory diseases, especially on account of the increasing count of tobacco smokers including the mounting pollution level is boosting the market domain.

Moreover, the involvement of the various public organizations in supporting the adoption of this medical gas equipment is further leading to propel the domain size. Additionally, announcements were made by the FDA in 2019, regarding the updating of its CGMP regulations to include a new design which is a necessity of oxygen supply to supply compartments and closure, including a new color and labeling to make them easily distinguishable and to further lead in reducing the risk of gas pollution.

MARKET DRIVER:

  • The rise in demand from hospitals is anticipated to spur the market growth

Medical gas and equipment play an imperative role in the hospital industries which are witnessing a significant surge in demand with the increasing number of hospitals across the globe. To deliver and provide efficient treatment to patients requiring critical care, there are various medical equipment such as cryogenic products, flowmeters, regulators, and even medical air compressors and others as well. This equipment is therefore mainstay in Intensive Care Units (ICUs) to Operation Theatres (OTs) across hospitals.

With such an increase in the demand for medical gas and equipment in the healthcare industry, multiple government funds in healthcare are increasingly investing which is driving the market growth. For instance, taking the example of India, the healthcare sector in India is expanding at a brisk pace, especially since the government has allowed foreign direct investment (FDI) in the industry. According to the World Health Organization (WHO), in Vietnam for every 1% increase in per capita GDP, public spending on healthcare has surged by 1.7% since 2000.

  • Rising incidence of chronic diseases will surge the growth of the market

The medical gas and equipment market is expected to experience sustained growth due to the increasing prevalence of chronic respiratory conditions, cardiovascular diseases, home healthcare needs, the aging population, critical care and emergency medicine, preventive healthcare measures, technological advancements, and increased focus on respiratory health. Chronic respiratory conditions like COPD and asthma require medical gases like oxygen for therapeutic purposes, while cardiovascular diseases, including heart failure, may require oxygen for patients experiencing respiratory distress. The growing preference for home healthcare fuels the demand for portable and home-use medical gas equipment, including devices for oxygen therapy and other respiratory support. Technological advancements in medical gas delivery systems and equipment contribute to improved patient care and management of chronic diseases. Public health campaigns and initiatives focusing on respiratory health also contribute to increased awareness of chronic respiratory conditions, leading to earlier diagnosis and treatment.

North America is anticipated to hold a significant amount of the market share

North America will witness a surge in this market during the projected period. The medical gas equipment market of North America dominates in terms of its market share and market revenue which is said to flourish its dominance during the forecast period. The presence of key players in the North American region along with the well-established healthcare including the pharmaceutical region is the few driving factors leading towards the dominance of North America in the medical gas equipment market. North America's advanced healthcare infrastructure, strict regulatory standards, high healthcare expenditure, technological advancements, and growing demand for home healthcare contribute to its dominant market position in the medical gas and equipment industry.

Additionally, the US is said to account for a higher sales value in the region which is further driven by the presence of multiple healthcare facilities. Furthermore, the current increase in the use of home-based therapy in the US is resulting in the medical gas equipment market experiencing a rise in standards and even analysis including various delivery procedures.

Market Key Developments

  • October 2023- Atlas Copco has acquired William G Frank Medical Gas Testing and Consulting, LLC and Medical Gas Credentialing LLC, both based in Concord, New Hampshire, USA. The acquisitions include medical and laboratory gas services, including annual inspections, consulting, preventative maintenance, parts supply, equipment sales, and professional development and training.
  • November 2022- ESAB Corporation has announced a retail partnership with Northern Tool + Equipment, a leading provider of high-quality tools and equipment. The partnership includes flagship products from ESAB's marquee brands, including ESAB, Victor(R) Gas Equipment, and Tweco(R), available in Northern Tool + Equipment's retail footprint, which includes over 125 stores in the Midwest and East Coast. The products are also available online at northerntool.com, providing welders and fabricators with a convenient purchasing path. The partnership is expected to expand as the companies continue to innovate and optimize their offerings.
  • January 2022- NOVAIR, a leading manufacturer of on-site gas production systems, has acquired OGSI, a USA-based manufacturer of industrial and medical oxygen generators. OGSI's solutions are designed for demanding applications like disaster preparedness, healthcare, and semiconductor manufacturing. As part of NOVAIR Group, OGSI and the US market will access a wide range of high-end solutions, including industrial and medical PSA oxygen & and nitrogen generators, high-pressure oxygen Cylinder Filling Systems, and Medical Air/Vacuum Systems. The acquisition strengthens NOVAIR's global presence and manufacturing capacity, with a new foothold in the USA.

Segmentation:

By Type

  • Medical Gas
  • Oxygen
  • Carbon Dioxide
  • Nitrogen
  • Nitrous Oxide
  • Medical Air
  • Helium
  • Medical Gas Equipment

By Application

  • Therapeutic Condition
  • Respiratory therapy
  • Cardiovascular Therapy
  • Others

By End-User

  • Hospitals
  • Home Healthcare
  • Pharmaceutical Companies
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Medical Gas
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
    • 5.2.4. Oxygen
    • 5.2.5. Carbon Dioxide
    • 5.2.6. Nitrogen
    • 5.2.7. Nitrous Oxide
    • 5.2.8. Medical Air
    • 5.2.9. Helium
  • 5.3. Medical Gas Equipment
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Therapeutic Condition
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Respiratory Therapy
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Cardiovascular Therapy
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. MEDICAL GAS AND EQUIPMENT MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Home Healthcare
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Pharmaceutical Companies
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Others
    • 7.5.1. Market Opportunities and Trends
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness

8. MEDICAL GAS AND EQUIPMENT MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Italy
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. South Korea
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. Others
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. The Linde Group
  • 10.2. Praxair Technology, Inc.
  • 10.3. Delta P S.r.l
  • 10.4. Rotarex
  • 10.5. SOL SPA
  • 10.6. Messer Group
  • 10.7. Medicop
  • 10.8. Amico Group of Companies
  • 10.9. Precision UK Ltd (a subsidiary of Indutrade)
  • 10.10. MEC Medical Ltd.
  • 10.11. Air Liquide
  • 10.12. Air Products and Chemicals, Inc.
  • 10.13. TAIYO NIPPON SANSO CORPORATION
  • 10.14. GCE Group
  • 10.15. Atlas Copco AB